Menu

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Projects

Group projects

A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00211-24
  • Start year: 2024
  • Funders: European Medicines Agency (EMA)

Antiseizure meDication Exposure and Pregnancy and neonaTal outcomes research (ADEPT). Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and adverse pregnancy, neonatal and child outcomes

  • Principal investigators: Rosa Morros Pedrós, Maria Giner Soriano
  • Code: 4RNC-0-00239-24
  • Start year: 2024
  • Funders: European Medicines Agency (EMA)

Non-interventional post-authorization multi-database safety study to assess the risk of myotoxicity and hepatotoxicity in statin-exposed heart failure patients with or without concomitant use of LCZ696

  • Principal investigators: Daniel Prieto Alhambra, Anna Berenguera Ossó
  • Code: 4R16/021
  • Start year: 2016
  • Funders: Synapse Research Management Partners, s.l.

Impulsant l”excel·lència de la recerca en Atenció Primària i l”ús de Real World Data per millorar la salut de la població – GoEurope

  • Principal investigators: Mariona Pujol Vidal, Mariona Pujol Vidal, Bonaventura Bolíbar Ribas
  • Code: 4R19/039
  • Start year: 2019
  • Funders: Generalitat Catalunya

Personas con experiencias y experticias en investigación y acciones participativas

  • Principal investigators: Constanza Jacques Aviñó
  • Code: 4R19/161
  • Start year: 2019
  • Funders: ICS - Institut Català de la Salut

Board of Trustees

Collaborators

Accreditations